Effect of PI-103 on DDP Chemotherapy of Human Ovarian Cancer Cell Line SKOV3/DDP

LIU Jun,CAI Yun-lang,REN Mu-lan,WU Di,ZENG Ya
DOI: https://doi.org/10.3969/j.issn.1671-6264.2013.05.011
2013-01-01
Abstract:Objective:To explore the effect of PI-103, a phosphatidylinositol 3′-kinase(PI3K)-mammalian target of rapamycin ( mTOR ) inhibitor , in DDP chemotherapy on cisplatin-resistance of human ovarian cancer cell line SKOV3/DDP.Methods:The SKOV3/DDP cells proliferation treated with PI-103 and DDP alone or in combin-ation was evaluated by CCK-8 assay .Flow cytometry was used to study cell apoptosis upon drug treatment .Western blot was used to detect the changes of protein kinase B ( Akt ) , phosphorylated Akt protein , S6 ribosomal protein (rpS6), phosphorylated rpS6 protein, Bcl-2 and Bax protein upon drug treatment.Results:PI-103 could effecti-vely inhibit the multiplication of SKOV3/DDP cells.The inhibition effect showed a dose-dependent and time-depe-ndent fashion .The inhibition ratio of SKOV3/DDP cells proliferation and the apoptotic index were increased more obviously by cisplatin in combination with PI-103 than both individually .PI-103 specifically abrogated the phosp-horylation of Akt and rpS 6 ,and enhanced up-regulation of Bax and down-regulation of Bcl-2 with DDP treatment . Conclusions:Inhibition of the PI3K/Akt/mTOR signaling pathway by PI-103,can enhance up-regulation of pro-apoptotic protein and simultaneously down-regulation of anti-apoptosis protein with DDP treatment , which finally induced cell growth inhibition and cell apoptosis in SKOV 3/DDP cells.PI-103 can effectively increase the chemotherapeutic effect of cisplatin on the cisplatin-resistance of SKOV3/DDP cells.
What problem does this paper attempt to address?